CytoAgents Receives Second Round of NIH Funding to Accelerate Treatment for Cytokine Storm

Retrieved on: 2021-03-10 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

CytoAgents Receives Second Round of NIH Funding to Accelerate Treatment for Cytokine Storm. View article details on hiswai:

Excerpt

GP1681 uses a novel approach by calming the natural immune response ... CytoAgents is a clinical stage biotechnology company focused on the ...

Article found on: www.pharmiweb.com